Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Dainippon Ink presents new antiallergic/antiasthmatic agent

June 18, 1997

Novel CCK-B antagonist with anxiolytic activity from Rotta

June 18, 1997

High-dose riboflavin for migraine prophylaxis

June 18, 1997

Targets for antimigraine therapy: SSRIs in the prevention of migraine

June 18, 1997

Targets for antimigraine therapy: NOS inhibitors as new therapeutic approach

June 18, 1997

Targets for antimigraine therapy: NK1 blockade not an effective antimigraine strategy

June 18, 1997

Targets for antimigraine therapy: inhibitors of neurogenic plasma protein extravasation

June 18, 1997

SKB describes development of 5-HT4 antagonists for IBS

June 16, 1997

Second-generation NNRTI under development by Hoechst/Bayer

June 16, 1997

Abbott describes SAR leading to prokinetic motilides

June 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...